Cargando…
First-year treatment costs among new initiators of topical prostaglandin analogs
OBJECTIVE: To estimate first-year costs among new initiators of topical prostaglandin analogs in a managed care population. RESEARCH DESIGN AND METHODS: We developed a model to estimate first-year direct medical costs. We derived treatment patterns from a claims database analysis. Published studies...
Autores principales: | Schmier, Jordana K, Covert, David W, Robin, Alan L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788590/ https://www.ncbi.nlm.nih.gov/pubmed/19997567 |
Ejemplares similares
-
First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results
por: Schmier, Jordana K, et al.
Publicado: (2010) -
Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs
por: Schmier, Jordana K, et al.
Publicado: (2010) -
Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs
por: Schmier, Jordana K, et al.
Publicado: (2014) -
Resource Utilization and Costs of Age-Related Macular Degeneration
por: Halpern, Michael T., et al.
Publicado: (2006) -
Treatment costs of cystoid macular edema among patients following cataract surgery
por: Schmier, Jordana K, et al.
Publicado: (2016)